开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2024-09-18 求求了，审稿人爸爸! 来自河南省

为啥我都提交一个月了，连编辑都找不到呢

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2024-05-31 ms8000000121798389 来自辽宁省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：帕金森;机器学习
经验分享：29 Feb 2024 Corresponding Author submitted manuscript.
26 Apr 2024 Review of Reviewer 2 is finalized.
17 May 2024 Interactive review forum activated.（小修）
19 May 2024 修回
24 May 2024 Review of Review Editor 3 finalized
27 May 2024 Article accepted for publication.

ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2022-05-31 ms9000001475187757

请问要求重新提交手稿或者联系编辑办公室，是为什么

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2024-03-28 ms8000001656880339 来自北京

目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办

85 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2024-01-08 夏江来自山东省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2021-11-15 ms5000000431732548

审稿速度:6.0 | 投稿命中率:50.0
经验分享：Date Updates
7-Oct-21 Article accepted for publication.
4-Oct-21 Review of Review Editor 2 finalized.
26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab.
20-Sep-21 Review Editor 2 posted new comments.
2-Sep-21 You posted new comments.
26-Jul-21 Interactive review forum activated.
19-Jul-21 Review of Reviewer 1 is finalized.
8-Jun-21 Corresponding Author resubmitted the manuscript.
7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript.
4-Jun-21 Corresponding Author submitted manuscript.
六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。
审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊

248 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2023-05-16 ms1000000298752898 来自江苏省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：脑卒中;分子流行病学
经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~

113 0

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2023-01-11 ms7000000237085851 来自天津

请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢

126 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2023-02-13 ms5000000505639371 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：AD
经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226326, encodeId=63b12226326a4, content=为啥我都提交一个月了，连编辑都找不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230227/03b06ca2145e474689d1a48c9926d9ed/95d9ada738354ed688baadd4678e2d3b.jpg, createdBy=66d08498734, createdName=求求了，审稿人爸爸!, createdTime=Wed Sep 18 08:56:22 CST 2024, time=2024-09-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2207704, encodeId=9b51220e70438, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：帕金森;机器学习 经验分享：29 Feb 2024 Corresponding Author submitted manuscript. 26 Apr 2024 Review of Reviewer 2 is finalized. 17 May 2024 Interactive review forum activated.（小修） 19 May 2024 修回 24 May 2024 Review of Review Editor 3 finalized 27 May 2024 Article accepted for publication. ps：审稿人1 三月份街道稿件一直没给意见，撤回审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6b88366687, createdName=ms8000000121798389, createdTime=Fri May 31 22:04:36 CST 2024, time=2024-05-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1223615, encodeId=cd491223615c4, content=请问要求重新提交手稿或者联系编辑办公室，是为什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c388171183, createdName=ms9000001475187757, createdTime=Tue May 31 15:48:28 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195901, encodeId=493e2195901f5, content=目前有一片review在这个杂志接收，但是导师医院拉黑了这个杂志，自己又付不起那么高的版面费，请问该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e406432489, createdName=ms8000001656880339, createdTime=Thu Mar 28 17:16:52 CST 2024, time=2024-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2179912, encodeId=a20121e9912b2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿还是很快的，审稿人也很NICE，没有很刁钻的问题，三个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIaR3b7TPx9crbDhPLt6ZeJJQl3PIdowbbuGLFGnZbM7PAmZuibREia20IOvL6HO8rxOD332VmfiaQaA/132, createdBy=a7602274330, createdName=夏江, createdTime=Mon Jan 08 10:03:57 CST 2024, time=2024-01-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1070458, encodeId=a01210e045896, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Date Updates 7-Oct-21 Article accepted for publication. 4-Oct-21 Review of Review Editor 2 finalized. 26-Sep-21 Corresponding Author Bin Wang posted new comments in the Editor tab. 20-Sep-21 Review Editor 2 posted new comments. 2-Sep-21 You posted new comments. 26-Jul-21 Interactive review forum activated. 19-Jul-21 Review of Reviewer 1 is finalized. 8-Jun-21 Corresponding Author resubmitted the manuscript. 7-Jun-21 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. 4-Jun-21 Corresponding Author submitted manuscript. 六月4号投稿，十月7号接受，审稿周期四个月，速度算是比较快了，过程也很顺利。一审审稿人1同意发表，审稿人2提了好多专业性意见。 审稿人都很nice，提的问题也非常专业。按照审稿人的意见修改后文章质量提升了很多。非常愉快的一次投稿经历😊😊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/e86f38748c0f45b1b79ac37f1b4a36fa/e97d59251da84631908e2fca18b3fc9e.png, createdBy=cbee5510180, createdName=ms5000000431732548, createdTime=Mon Nov 15 17:09:41 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2135324, encodeId=1eb32135324ca, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：脑卒中;分子流行病学 经验分享：第一篇从投稿到见刊不到2个月；第二篇从投稿到见刊差不多3个月。审稿人提的问题还挺专业，除了有一个要引用他的一篇文章外。整体速度还行，第一篇速度是真的很快，非常愉快。第二篇稍微有点慢，但总体已经很快了。祝大家好运~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0e38167431, createdName=ms1000000298752898, createdTime=Tue May 16 16:23:52 CST 2023, time=2023-05-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2109809, encodeId=8bb1210980991, content=请问这个杂志目前审稿很慢，几个月也没有动静，是因为自身稿件质量的原因吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31148486206, createdName=ms7000000237085851, createdTime=Wed Jan 11 12:59:14 CST 2023, time=2023-01-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2114464, encodeId=bb6821144647d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：AD 经验分享：一个月前投的，两周前两个审稿人拒稿并退出，编辑目前还没找到新的审稿人，是不是悬了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ad6390815, createdName=ms5000000505639371, createdTime=Mon Feb 13 19:42:21 CST 2023, time=2023-02-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2112864, encodeId=d1ad21128643f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：帕金森病 经验分享：2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 修回 2022/01/10 Review 1 Endorsed 2022/01/17 催稿，Review2 新增意见 2022/01/19 修回 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Fri Feb 03 11:28:01 CST 2023, time=2023-02-03, status=1, ipAttribution=江苏省)]

2023-02-03 雪亦飘零久来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：帕金森病
经验分享：2022/11/07 Initial Validation; Editorial Assignment

2022/12/13 Independent Review

2022/12/28 Substantial revision

2022/01/08 修回

2022/01/10 Review 1 Endorsed

2022/01/17 催稿，Review2 新增意见

2022/01/19 修回

2022/01/23 Review 2 Endorsed; Review Finalized

2022/01/23 Accept

132 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务